Day One Biopharmaceuticals (DAWN) Receivables - Net (2024 - 2025)
Day One Biopharmaceuticals (DAWN) has disclosed Receivables - Net for 2 consecutive years, with $26.7 million as the latest value for Q4 2025.
- On a quarterly basis, Receivables - Net rose 92.67% to $26.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $26.7 million, a 92.67% increase, with the full-year FY2025 number at $26.7 million, up 92.67% from a year prior.
- Receivables - Net was $26.7 million for Q4 2025 at Day One Biopharmaceuticals, up from $16.7 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $26.7 million in Q4 2025 to a low of $8.7 million in Q3 2024.